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Sexual aspects of liver transplant candidates and recipients:  
evidence available in the literature1
Objective: to analyze the evidence available in the literature on the alterations in the sexuality 
of candidates and recipients of liver transplantation. Method: integrative review of the literature 
with search for primary studies in the databases MEDLINE (via PUBMED), CINAHL e LILACS, 
published in English, Portuguese and Spanish. Results: the 16 primary studies included were 
grouped into three categories: 1) female sexuality (n=5), 2) male sexuality (n=5) and 3) 
male and female sexuality (n=6). In category 1, the subjects investigated were contraception, 
pregnancy, sexual dysfunction, presence of gynecological symptoms and sexually transmitted 
infections. In category 2, the main focus of the studies was erectile dysfunction, sexual desire 
and satisfaction, and consequences of the immunosuppressive regimen with mycophenolic acid 
in men. In category 3, the evaluation of sexual function was the main topic. Conclusion: the 
scientific evidence generated provides support to encourage health professionals to incorporate 
the topic of sexuality in the routine of care. Knowledge gaps were identified and new studies 
should be conducted in order to implement interventions to prevent, minimize and/or control 
changes related to the patient’s sexuality.
Descritores: Perioperative Nursing; Sexuality; Liver Transplantation; Review; Health Services; 
Transplant Recipients.
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Introduction
End-stage liver disease significantly reduces quality 
of life. In this context, the transplantation can reverse the 
terminal stage and improve the patients’ health conditions(1).
According to the World Health Organization (WHO), 
sexuality is a central aspect of being human throughout the 
life cycle that encompasses sex, gender identities, sexual 
orientation, eroticism, pleasure, intimacy and reproduction. 
It is manifested in different forms by the individuals and can 
be influenced by the interaction of biological, psychological, 
social, economic, political, cultural, historical and religious 
factors(2). In general, there is evidence in the literature that 
both liver transplant candidates and recipients may suffer 
some degree of sexual dysfunction, either temporary or 
permanent(3).
In liver transplant candidates, sexual dysfunction is 
common and related to the changes triggered by the chronic 
liver disease, to the drug therapy, hormonal changes, 
irrigation of the pelvis and emotional changes. Men may 
experience symptoms such as difficulty in erection, loss of 
libido, premature ejaculation and oligospermia. Women may 
be affected by ovarian dysfunction, amenorrhea, decreased 
or absent libido and infertility. Sexual health is complex 
because it involves different factors, such as age, use of 
medications, and social and psychological aspects coming 
from previous experiences or from the transplantation(4-5).
The feelings of well-being and improved clinical status 
after transplantation are related to the success of the 
procedure. However, problems such as the side effects of 
immunosuppressive drugs and the risk of postoperative 
complications, such as the possibility of graft failure, 
rejections and vascular thrombosis, may be stressors 
for the patient(6). Liver transplantation can improve the 
patients’ quality of life; however, there is evidence that 
not all patients experience the same benefits(7).
The chronic condition of the patient in both phases 
of transplantation (before and after surgery) represents a 
battle for quality of life, which is altered by the disease and 
by the treatment it requires(7). Thus, one of the first aspects 
of life affected by the physical and emotional symptoms 
is sexual function(8). With the prospect of performing the 
transplant, the patient focuses his thoughts on survival 
and recovery. After the transplant, new perspectives and 
life plans emerge, allowing the resumption of intimacy and 
favoring sexual activity(4).
Sexuality is a complex area of  human behavior and 
it should not be underestimated, both for the transplant 
candidate and the transplant recipient. Sexual function is 
influenced by disease, psychological distress, and imbalance 
of interpersonal relationships. In most cases, chronic 
disease is associated with sexual dysfunction and results 
in decreased sexual activity due to discomfort, fatigue 
and changes in body image, which significantly affects the 
patient’s relationship with the partner(7,9).
A systematic review with meta-analysis of observational 
studies aimed to evaluate the effect of liver transplantation 
on endocrine and sexual function in adult patients. The 
results suggested that liver transplantation improves the 
hormonal perturbations associated with chronic liver disease 
by restoring physiological levels of growth hormone, insulin-
like growth factor, testosterone, estradiol, prolactin, follicle-
stimulating hormone and luteinizing hormone. The 21 
studies analyzed demonstrated that liver transplantation 
was associated with improved sexual function(8).
Given the above and considering that the subject 
of sexuality of candidates and recipients of solid organs 
is scarcely investigated, specifically regarding liver 
transplantation, and that health professionals need to 
be prepared to address this issue with patients in health 
services, the interest in conducting this integrative review is 
justified, since its results can generate evidence to support 
the care provided. Thus, the objective of the present review 
was to analyze the evidence available in the literature on 
the changes in the sexuality of candidates and recipients 
of liver transplantation.
Method
Integrative review (IR) of the literature was the 
method of knowledge synthesis used. For this method, 
five steps were taken: elaboration of the research 
question (identification of the problem), literature search 
for primary studies, evaluation of primary studies, data 
analysis and presentation of the review(10).
To guide the IR, based on the PECOT strategy 
(acronym for patient, exposure, comparison, outcomes 
and time), the following question was formulated: “What 
evidence is available in the literature about changes in the 
sexuality of liver transplant candidates and recipients?”. 
The first element (P = patient or problem) are the 
candidates and recipients of liver transplantation, the 
second (E = exposure) is sexuality, the third element (O 
= outcomes or results) are alterations related to sexuality 
and (T=time) is the pre- and post-operative periods.
The search for primary studies was performed 
through an online search in three health databases: 
Medical Literature Analysis and Retrieval System Online 
(MEDLINE via PUBMED), Cumulative Index to Nursing and 
Allied Health Literature (CINAHL) and Latin- American 
and Caribbean Health Sciences (LILACS).
The descriptors and keywords were established 
according to each database in order to guarantee a 
rigorous and broad search for the primary studies on the 
topic of interest, and were associated with the PECOT 
acronym (Figure 1). In order to search the publications 
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in each database, the descriptors and the keywords were 
crossed with each other through tactical operations, using 
the Boolean operators AND and OR.
For the selection of the primary studies of this 
review, the following inclusion criteria were adopted: 
primary studies whose authors investigated the 
changes in the sexuality of candidates or recipients of 
liver transplantation, which were published in English, 
Portuguese and Spanish in the last 10 years (from June 
30th, 2006 to June 30th, 2016). The time period was 
established to ensure an adequate number of studies, 
considering that a large number of primary studies could 
make it impossible to conduct the integrative review or 
introduce biases in the next steps of the method.
From the results of the search strategies used in the 
databases selected for the review, a file was imported 
into the EndNote reference manager, version X5. For the 
management of references, folders were created for each 
database and duplicate studies, books, dissertations, 
thesis and other non-scientific texts, studies written in 
languages other than the established ones or published 
outside the established period were filtered. The pre-
selection of the primary studies through the reading of 
the titles and abstracts was performed and, finally, the 
final selection of the studies for reading in full. Figure 2 
shows the flowchart for the selection of primary studies.
An instrument developed by a national researcher 
was used to extract data from primary studies. 
The instrument contains a set of items that enable 
the identification of researches, methodological 
characteristics, main results and conclusions(11). 
For the evaluation of the studies, the definition of 
the type of research described by the authors was 
maintained and, when this information was absent, the 
concepts described by nursing researchers in scientific 
methodology were used to classify the methodological 
approach used in the research(12).
The hierarchy of evidence was classified according 
to the type of clinical question of the studies. The clinical 
question may be: (a) of significance (with five levels of 
evidence, the strongest being level I, evidence obtained 
from the meta-synthesis of qualitative studies, and 
the lowest, level V, evidence from expert opinion); (b) 
of prognosis, prediction or etiology (with five levels of 
evidence, the strongest being level I, evidence obtained 
from the synthesis of cohort or case-control studies, and the 
lowest, level V, evidence from expert opinion specialists) and 
(c) of intervention, treatment or diagnosis/diagnostic test 
(with seven levels of evidence the strongest being level I, 
evidence obtained from systematic review or meta-analysis, 
and the lowest, level VII, evidence from expert opinion)(13).
The synthesis of the results of the review was 
descriptive. Thus, the 16 primary studies included in the 
review sample were grouped into three categories: (1) 
“female sexuality” (n=5), (2) “male sexuality” (n=5), and 
(3) “male and female sexuality” (n=6).
Acronym
Descriptors and keywords
MEDLINE/PUBMED CINAHL LILACS
P1*
End Stage Liver Disease
Waiting Lists
Chronic xLiver Failure
Liver Failure
Waiting Lists
Pretransplantation Period
End Stage Liver Disease
Wait List
Transplantation Waiting Period
Pre-Transplant Period
Pre-transplantation Period
Listas de Espera
Falência Hepática
Doença Hepática Terminal
Falência do Fígado
Insuficiência Hepática Grave
Insuficiência do Fígado Grave
Doença Hepática em Estágio Final
Doença Hepática em Estágio Terminal
Hepatopatia em Estágio Final
Hepatopatia em Estágio Terminal
P2†
Transplant Recipients
Transplantation
Organ transplantation
Liver Grafting
Liver Transplantation
Hepatic Transplantation
Transplant Recipients
Organ Recipients
Liver Transplantation
Recipient Transplantation, Liver
Pessoas Transplantadas
Transplantados
Receptores de Transplantes
Transplante de Fígado
E + O‡
Sexual Dysfunction, Psychological
Sexual Dysfunctions, Psychological
Erectile Dysfunction
Sexuality
Erectile Dysfunction
Sexual Dysfunction
Sexualidade
Disfunção Sexual Fisiológica
Disfunção Erétil
T1§
Preoperative Period
Preoperative Care
Preoperative Procedure
Presurgical Period
Presurgical Care
Preoperative Period
Preoperative Care
Período Pré-Operatório
Cuidados Pré-Operatórios
Assistência Pré-Operatória
T2||
Postoperative Period
Postoperative Care
Postoperative Procedure
Postsurgical Period
Postoperative Period
Postoperative Care
Postsurgical Care
Período Pós-Operatório
Cuidados Pós-Operatórios
Assistência no Período Pós-Operatório 
Cuidados Pós-Cirúrgicos
*P1 = patient crossing 1; †P2 = patient crossing 2; ‡E+O = exposure crossing + outcomes; §T1 = time crossing 1; ||T2 = time crossing 2
Figure 1 – Descriptors and keywords selected in each database according to the acronym PECOT
www.eerp.usp.br/rlae
4 Rev. Latino-Am. Enfermagem 2018;26:e3033.
Results
Regarding the database, 13 primary studies 
(81.2%) were identified in Medline (via PubMed) and 
three (18.7%) in CINAHL. Regarding the country 
of origin, six studies (37.5%) were from the United 
States of America, three (18.75%) from Poland, three 
(18.75%) from France and one (6.25%) from Canada, 
Switzerland, China and Taiwan, respectively. It was 
observed that 87.5% (n=14) of the primary studies 
were published in medical journals. Regarding the 
period of publication, one study (6.25%) was published 
Figure 2 – Flowchart for the selection of primary studies
in 2001, three (18.75%) in 2006, one (6.25%) in 2008, 
two (12.5%) in 2009, four (25%) in 2013, four (25%) 
in 2014 and one (6.25%) in 2015.
The type of clinical question of all the primary 
studies included was Prognosis/Prediction or Etiology. 
Fourteen investigations (87.5%) were classified as level 
of evidence IV (evidence from a single qualitative or 
descriptive study) and two (12.5%) were classified as 
Level of Evidence II (evidence from a single cohort or 
case-control study). In Figures 3, 4 and 5, the knowledge 
synthesis of the primary studies included in the review is 
presented, according to each category.
Author(s) Objective Main results LE*
Gomez-Lobo 
et al.(14)
To determine gynecologic 
symptoms and sexual function 
in candidates and recipients of 
liver transplantation. 
The rates of amenorrhea were 44% for candidates and 27% for recipients. There was 
greater prevalence of amenorrhea in patients with hepatocellular cirrhosis compared 
with cholestatic disease. The transplanted women reported a more intense menstrual 
period and a lower frequency of urinary incontinence than the candidates.
IV
Tarallo et 
al.(15)
To assess the prevalence and 
risk factors for high-risk HPV† 
infection among female liver 
transplant candidates.
Pap smear was normal in 58 participants (93.5%), while five (6.5%) had atypical 
squamous cells of undetermined significance. The HPV† test identified 10 women 
(16.1%), ages 46-61 years, with the high-risk virus. All women with high-risk HPV† had 
hepatic cirrhosis due to the hepatitis C virus, and 90% of them had no risk factors for 
HPV† (p=0.0013). 
IV
Szpotanska-
Sikorska et 
al.(16)
To evaluate the proportion of 
contraceptive users and the 
level of satisfaction during the 
pre- and post-transplantation of 
kidney and liver.
Of the recipients of liver transplantation, 33% were unaware of the need to prevent 
pregnancy after surgery. Those who used drugs contraindicated for pregnancy only 
became aware of the situation when they became pregnant. Only 30% of kidney 
recipients and 29% of liver recipients used contraceptive methods. There was an 
increase in the use of contraceptives in sexually active women after liver transplantation. 
The choice of contraceptives depended on medical recommendation and on the 
absence of interference of the method in the body.
IV
Szymusik, et 
al.(17)
To assess whether female graft 
recipients apply proper family 
planning methods and use 
effective contraception.
There was improvement in the regularity of the menstrual cycle after liver 
transplantation. Liver transplant recipients became sexually more active postoperatively. 
After surgery, 18 women became pregnant, of which 6 (33.3%) were unplanned 
pregnancies. Sexually active transplanted women used fewer contraceptives than 
women in the control group. In addition, sexually active transplant recipients with chronic 
diseases used IUDs‡ more often than women in the control group.
II
Rafie et al.(18)
To evaluate counseling on 
the use of contraceptives and 
contraceptive methods among 
women after solid-organ 
transplant.
67% of transplanted women received counseling on pregnancy. Only 33% of the 
patients reported they had received information on the risk of pregnancy in the 1st year 
of transplantation, and 90% were aware of the risk of fetal deformity. The condom was 
the most used method. No patient received orientation from the gynecologist. 48% of the 
recipients were interested in receiving orientation on effective methods such as the IUD‡.
IV
*LE=level of evidence; †HPV= human papillomavirus infection; ‡IUD= intrauterine device
Figure 3 – Characteristics of the primary studies included in the category “female sexuality”. Ribeirão Preto, SP, Brazil, 2017
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Author(s) Objective Main results NE*
Huyghe et al.(19)
To determine the frequency 
and risk factors for ED† and 
satisfaction with erection among 
men after liver transplantation. 
15% of recipients were sexually inactive after transplantation, 5% were active 
before surgery and became sexually inactive after, 10% remained inactive in both 
periods and 19% became sexually active after transplantation. The absence of 
sexual activity after surgery was associated with age, history of cardiovascular 
disease, use of diuretics, anticoagulants, non-steroidal anti-inflammatory drugs, 
statins and treatment for diabetes mellitus. 
IV
Huyghe et al.(20)
To determine the prevalence 
and risk factors for ED† in men 
with end-stage liver disease 
candidates to liver transplantation.
Of the participants, 28.6% were considered sexually inactive. Among the 
sexually active, 74% had ED†. The risk factors for this condition were alcohol 
intake, tobacco use and cardiovascular disease. The risk factors for low sexual 
satisfaction were viral hepatitis and cardiovascular disease. Concern about 
erection was cited by 61.4% of sexually active men.
IV
Wang et al.(21)
To assess ED† in men with hepatic 
failure due to benign disease, 
candidates and recipients of liver 
transplantation.
Liver transplant recipients were more sexually active than the candidates. For 
the recipients, the mean time to restore libido was 60 days and the mean time 
to recover sexual activity was 90 days after surgery. Severe and total ED† were 
higher among candidates. Recipients that used cyclosporine presented less 
problems with ED †.
IV
Jones et al.(22)
To describe the outcomes of 
pregnancies with exposure to 
mycophenolic acid at the time of 
conception.
Of 830 men enrolled in the NTPR, 152 were exposed to mycophenolic acid, 
generating 205 pregnancies, of which 194 were live births and 14 spontaneous 
abortions. Of the live births, 10.8% were premature, 4.1% were born with low 
weight and 3.1% presented malformations, which was similar to the general 
population.
IV
Chien et al.(23)
To assess differences in erectile 
and sexual function in the pre- 
and post-surgical period of liver 
transplantation with a living donor.
Erectile function improved significantly after transplantation. Hypogonadism before 
surgery was associated with improvement in erectile function after transplantation. 
There was a significant correlation between hypogonadism and erectile function 
before liver transplantation. 
IV
*LE= level of evidence; †ED=erectile dysfunction; ‡NTPR=National Transplant Pregnancy Registry 
Figure 4 - Characteristics of the primary studies included in the category “male sexuality”. Ribeirão Preto, SP, Brazil, 2017
Author(s) Objective Main results LE*
Ho et al.(24)
To describe the frequency and 
extent of SD† in liver transplant 
recipients before and after 
surgery.
23.8% of men and 24.1% of women had sexual problems before surgery, with evolution 
to 51.1% and 40.3%, respectively, after transplantation. Men reported decreased libido, 
problems with premature ejaculation, erectile dysfunction and difficulties reaching 
orgasm after surgery. Women reported decreased libido, difficulty maintaining lubrication, 
dyspareunia, and inability to reach orgasm after transplantation.
IV
Sorrell 
et al.(25)
To assess the prevalence 
of SD† in cases of liver 
failure, before and after liver 
transplantation.
Increased age and more severe liver disease were related to lower sexual frequency and 
satisfaction. There was persistence of SD† after surgery. Interest (35.1%) and ability to reach 
orgasms (45.4%) increased after surgery, but frequency (38.9%) and satisfaction (44.4%) 
decreased during this period.
IV
Burra(26)
To assess the prevalence of 
SD† in patients with HC‡ and 
patients submitted to liver 
transplantation. 
Women with HC‡ had a decrease in testosterone levels and increase in prolactin and 
delta-4 androstenedione compared to transplant recipients. Men with HC‡, had higher 
levels of prolactin and sex hormone binding globulin compared to transplant recipients. 
The percentage of severe erectile dysfunction was higher in CH‡ patients than in transplant 
recipients.
IV
Park 
et al.(27)
To assess SD† and sexuality of 
liver transplant recipients. 
Males presented moderate to severe SD† and erectile dysfunction. 58.8% of women had SD†. 
Personal suffering related to sexuality was significant in women (40.6%) and in men (62,9%).
IV
Klein 
et al.(3)
To assess sexual function 
and conjugal satisfaction in 
candidates and recipients of 
liver transplantation.
In men, sexual function improved after surgery when compared to transplant candidates, 
but was worse compared to healthy subjects. In women, the sexual function improved in 
the post-operative period when compared with female candidates. Age, body mass index, 
hypertension, diabetes mellitus and dyslipidemia were associated with worsening of sexual 
function after liver transplantation in men and women.
II
Grat 
et al.(28)
To analyze the prevalence 
and risk factors of anal HPV§ 
infection in liver transplant 
recipients.
The prevalence of anal HPV infection§ was 18%. Anal HPV§ infection rate was higher in 
patients with the hepatitis B virus, with three or more sexual partners and alcoholic HC ‡. 
Hepatitis B infection was a factor associated with high-risk HPV infection.
IV
*LE=level of evidence; †DS=sexual dysfunction; ‡HC= hepatic cirrhosis; §HPV= human papillomavirus infection 
Figure 5 - Characteristics of the primary studies included in the category “male and female sexuality”. Ribeirão Preto, 
SP, Brazil, 2017
Discussion
Primary studies grouped in the category “female 
sexuality” had as main topics of investigation: 
contraception and pregnancy(16-18), sexual dysfunction 
and of gynecological symptoms(14), and sexually 
transmitted infections(15). In women, hepatic cirrhosis 
can lead to the development of amenorrhea, 
premature menopause and infertility due to reduced 
secretion of gonadotropins. In addition, low estradiol 
levels lead to reduced libido, vaginal dryness and 
dyspareunia(14,16-17).
In the category “male sexuality”, erectile dysfunction 
was the main focus of the studies(19-21,23). In two 
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studies, the authors also investigated sexual desire 
and satisfaction(19-20) and one study(22) investigated the 
consequences for newborns generated by men who 
impregnated their partners while using drugs with 
mycophenolic acid.
In the category regarding both genders, the 
evaluation of sexual function was the main topic of 
the primary studies. In three studies, measurements 
were made using the International Index of Erectile 
Function (IIEF) and Female Sexual Function Index 
(FSFI)(3,26-27). The authors also used other scales, such 
as: the Beck Depression Inventory (instrument to 
evaluate depression), the Short Form (36) Health Survey 
(scale to evaluate quality of life)(26), the Locke-Wallace 
Marital Adjustment Test (instrument to evaluate marital 
satisfaction)(3) and the Female Distress Scale – Revised 
(FSDS-R), a scale that evaluates personal suffering 
related to sexuality(27). In two studies(24-25), the authors 
adopted their own data collection questionnaire.
In transplanted women, the menstrual cycle 
returns to normal up to one year after surgery, allowing 
women of childbearing age to be mothers after one or 
two year of their transplantation, according to doctor’s 
recommendations(14,29). However, transplanted women 
need special care due to the use of teratogenic drugs 
during time of pregnancy. Therefore, pregnancy must be 
planned in order to avoid maternal-fetal complications 
and transplant graft dysfunction. The results of the 
primary studies included in the review (n=3) showed 
that transplanted women were little aware of the 
problem and health professionals did not provide 
proper orientation about the need for family planning 
and effective contraceptive methods. Therefore, female 
transplant recipients exposed themselves, the fetus and 
the organ received to risks(16-18).
There are gaps in knowledge about which 
contraceptive method is recommended for transplanted 
women. In some studies, the authors contraindicate the 
use of the IUD, due to the potential risk of infection, 
especially in people with immunosuppression(30-31). In 
other studies, the authors argue that the use of the 
intrauterine device by transplanted women is safe 
and the greater occurrence of pelvic infection due to 
immunosuppression is a myth, and there is no absolute 
contraindication for its use(32-33). Therefore, further 
studies are necessary to investigate which contraceptive 
methods are most suitable for this group of women. 
However, it is clear that the method of choice should 
be one that does not present drug interaction with 
immunosuppressants and that does not pose a risk to 
the health of the transplant recipient. The need to use 
condoms is emphasized, since, despite having a failure 
rate of 18%, the condom is still the only barrier method 
capable of preventing against sexually transmitted 
infections(34).
It is necessary to conduct studies on the type 
of delivery most appropriate for women who were 
submitted to transplantation. Vaginal birth can minimize 
complications that could occur in a caesarean section, 
since women who underwent transplant surgery are 
likely to have adhesions and fibrosis resulting from 
abdominal surgery. However, because the gestation 
of these women is considered of high-risk, caesarean 
sections occur more often than vaginal delivery(35-37). It 
is evident that the route of delivery selected should be 
one that does not cause risks to the health of the fetus 
and the mother.
Breastfeeding by transplant mothers is a 
controversial subject, and scholars must conduct future 
research on the care of newborns. Breastfeeding is 
discouraged by some authors, while others question 
the benefit-risk of depriving the newborn of maternal 
nutrition, since the fetus has already been exposed to 
immunosuppressive drugs during gestation. In addition, 
the amount of drugs excreted in breast milk would not 
be sufficient to cause harm to the baby(37-39).
As a suggestion, it would be of great value to create 
a Brazilian registry system on pregnant women and 
transplant recipients, so that post-transplant maternity 
and paternity and the effects of drugs on fertility, 
pregnancy and conception could be investigated. In 
addition, transplantation centers in Brazil must record 
data regarding this problem in the Transplant Pregnancy 
Registry International.
Regarding the health of children generated by 
parents using immunosuppressive drugs, according to 
the Food and Drug Administration (FDA), the prevalence 
of health problems observed was similar to outcomes 
found in the general population(22).
The guidance and orientation provided by health 
professionals about birth control and the use of 
contraceptive methods cannot be only for the female 
audience, since men who want to be fathers also require 
care during the pregnancy of the partner. This is due to 
the use of teratogenic immunosuppressive drugs during 
conception, as well as the use of some classes of anti 
rejection drugs that provoke testicular toxicity, affecting 
male fertility(22,40).
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In men, clinical signs of hypogonadism include 
gynecomastia, hair thinning, testicular atrophy, 
reduction of the prostate and oligospermia, resulting 
in complications such as erectile dysfunction and 
decreased libido and fertility. The etiology of terminal 
liver disease is a risk factor for the occurrence of erectile 
dysfunction. In alcoholic cirrhosis the chance of having 
this dysfunction is greater, since alcohol has toxic effects 
and exerts direct action on the pituitary axis, interfering 
in the production of hormones such as testosterone and 
impairing sexual health(19,21,23).
Decreased libido and sexual interest were identified 
in both genders. The transplant can recover the patient’s 
health by replacing the diseased organ with a healthy one, 
and theoretically, the pathologies involved in the cause 
of sexual dysfunction are resolved. However, different 
factors are involved in the success of the transplantation 
and the organ replacement requires special lifelong care 
and may cause secondary problems. Thus, transplantation 
is not always capable of restoring the full sexual function 
of the transplanted individuals and, when there is an 
improvement, it is still lower than in the general population, 
and may take up to eighteen months to occur(19).
In the analysis of the occurrence of sexual 
dysfunction in men and women who were candidates 
and recipients of other solid organs such as kidney and 
heart, the results were similar to those identified in liver 
transplantation, that is, not all transplanted patients 
presented global recovery of sexual health. The prognosis 
of sexual dysfunction is related to the sexual function 
presented by the individual before being affected by the 
disease that led to the transplantation. In other words, 
patients who had good sexual health, even with sexual 
function impaired by the disease, had a greater chance 
of recovery after transplantation than those who already 
had low sexual health prior to disease(41).
The results of studies included in the review pointed 
out that contraceptive counseling for men and women 
is deficient and often occurs at an inappropriate time, 
that is, shortly after transplantation, when the recipient 
receives a high amount of information and goes through 
new experiences that require an adaptation phase, even 
if the person has been well prepared, theoretically, for 
the confrontations subsequent to surgery(16-18). When 
the guidelines for birth control are not assimilated or 
incorporated because the patient is focused on recovery 
after transplantation, sexuality will become more 
important after primary basic needs are met.
The risk of contracting sexually transmitted 
infections is higher in the transplanted population 
because of the degree of immunosuppression. In 
the phase prior to transplantation, liver disease also 
depresses the patients’ immune system, favoring the 
development of HPV. The chances of this pathology 
increase when the etiology of cirrhosis is the hepatitis 
C virus, in both men and women, causing lesions in the 
cervical, uterine and anal regions. Therefore, this public 
should receive greater attention regarding the screening 
of cancer precursor lesions related to HPV infection 
or activation. This evaluation should be performed 
with greater frequency in transplant candidates and 
recipients, since women with immunosuppression 
present a higher risk of developing cervical cancer when 
compared to healthy women(15,42).
As already pointed out, the majority (n=14) of the 
primary studies included in the review was classified 
with level of evidence IV (qualitative or descriptive 
study), indicating the need to conduct future research 
with strong designs on the issue of interest, providing 
evidence that can generate impact on decision making. 
No study was identified in the LILACS database, which 
may indicate lack of publications on the topic of interest 
in Latin American and Caribbean journals.
Conclusion
The sexual alterations most prominent among 
candidates and recipients of liver transplant were sexual 
dysfunctions, manifested in men by impotence and in 
women by amenorrhea and dyspareunia. Decreased 
libido and sexual interest was also evident in this public.
Satisfactory sexual health is fundamental for quality 
of life and, therefore, must be part of the anamnesis. 
Thus, the qualification of health professionals for the 
acquisition of knowledge and development of skills to 
address this issue with patients is of great relevance, 
considering, above all, their difficulties in exploring 
the sexual health of patients. The taboo on individual 
and cultural experiences with sexuality, as well as lack 
of training since college, influences the professional 
performance, since sexuality is underestimated and 
considered less relevant than the other problems 
presented by the patients.
The synthesis of knowledge indicated the need to 
intensify efforts for the development of studies with 
methodologies capable of producing strong evidence, 
since the studies analyzed did not present robust levels 
of evidence. In addition, there is a scarce production 
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of national research on sexuality in liver transplant 
candidates and recipients, as well as of studies that 
assess the long-term consequences of transplantation 
in the sexuality of men and women affected by chronic 
liver disease. Therefore, it is necessary to conduct future 
research on this subject. The incorporation of evidence 
into clinical practice can help the implementation of 
actions and interventions effective for patient care, 
according to their preferences, and support health 
professionals in the decision making process.
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